Skip to content
Screener

Disc Medicine IRON Q1 2026 earnings

Reported May 5, 2026 · Before market open

EPS-$1.65Miss by $0.10
Revenue estimate$437.5K
EPS estimate-$1.55

Next report

Nov 5, 2026 (in 3 months)
Revenue estimate$1.9M
EPS estimate-$1.64

Financials

Q1 2026

Income statement

See full
Operating income-$69.5M-74.0%
Net income-$63.5M-86.3%
EPS (diluted)-$1.65-61.8%

Balance sheet

See full
Cash & equivalents$88.9M-27.5%
Total debt$31.1M+1.4%
Total equity$688.4M+4.3%
Total assets$750.2M+5.8%

Cash flow

See full
Operating cash flow-$62.2M-50.4%
CapEx--100%
Free cash flow-$62.2M-47.4%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$2.44B+42.2%
Enterprise value$2.38B+46.7%

Returns & leverage

See full
Return on equity-35.8%+41.3pp
Debt / equity0×0.0×
Current ratio24×-13.6×

FAQ

When did Disc Medicine report Q1 2026 earnings?
Disc Medicine (IRON) reported Q1 2026 earnings on May 5, 2026 before market open.
What were Disc Medicine's Q1 2026 revenue and EPS?
Disc Medicine reported eps of $-1.65 for Q1 2026.
Did Disc Medicine beat estimates in Q1 2026?
EPS missed the consensus estimate of $-1.55 by $0.10.
How did Disc Medicine's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 61.8% from $-1.02.
Where can I find Disc Medicine's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-205187) and the 10-Q periodic report (0001193125-26-205192) directly on SEC EDGAR. The filing index links above go to sec.gov.